65,437 trials
Femoral Artery Stenosis · Popliteal Artery Stenosis · Femoral Artery Occlusion
Primary: Primary Patency — 82.2; 52.4 Percentage of participants — p=<0.001
Defective; Circulation
Primary: Change in Skin Perfusion Pressure (SPP) — 17.68 percentage of change — p=<0.05
Lung Cancer
Primary: Clinical Response as Assessed Metabolically by Changes in Positron Emission Tomography (PET) Scan Between Baseline and Immediately Prior to Surgery. — 78; 64; 50; 22…
Bronchiolitis
Primary: Duration of Hospital Stay — 3.9; 2.1 days
Metastatic Colorectal Cancer
Primary: Response Rate of Lapatinib/Capecitabine. — 4; 1 participants
Restless Legs Syndrome
Primary: Apparent Total Body Clearance (Cl/f) of Unconjugated Rotigotine 0.5 mg/24 h (2.5 cm^2) — 676.86 L/h (liter per hour)
Rheumatoid Arthritis
Primary: Change in Disease Activity Score Based on 28-Joint Count (DAS28) From Week 16 to Week 28 — 5.42; 5.29; 1.77; 1.96 units on a scale — p=0.700
Opioid Dependence
Primary: Incidence of Subject Re-arrest — 6; 2 participants re-arrested — p=>0.05
Primary Peritoneal Cavity Cancer · Recurrent Ovarian Epithelial Cancer
Primary: Tumor Response — 14.3 percentage of participants
Low Back Pain
Primary: Change in McGill Pain Questionnaire - Short Form — -0.73; -3.78 units on a scale
Malaria
Primary: Individual Parasite Reduction Ratio (PRR) — 1132; 217646; 314040; 8021 none (ratio)
HIV Infections
Primary: Time to Confirmed Virologic Failure — 28; 29 weeks
Chiari Malformation
Primary: Physical Health Quality of Life — 31.4; 35.61 units on a scale
Fatigue
Primary: Self-Reported Fatigue at End of Shift Work — 2.17; 1.78 units on a scale — p=0.0830
Chronic Kidney Disease
Primary: Systolic Blood Pressure (SBP) — 135.1; 134.4 mmHg — p=0.57